E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/2/2012 in the Prospect News PIPE Daily.

MYOS reports plans to conduct $5.6 million private placement of stock

Company sells about 22.4 million common shares at $0.25 apiece

By Devika Patel

Knoxville, Tenn., July 2 - MYOS Corp. negotiated a private placement of stock to raise about $5.6 million on July 2, according to an 8-K filed Monday with the Securities and Exchange Commission. Chardan Capital Markets, LLC is the agent.

The company will sell about 22.4 million common shares at $0.25 per share, a 46.81% discount to the June 30 closing share price of $0.47.

Settlement is expected July 6.

The Cedar Knolls, N.J., company develops and commercializes therapeutic products, nutritional supplements and other technologies to improve the health and performance of muscle tissue.

Issuer:MYOS Corp.
Issue:Common shares
Amount:$5.6 million (approximate)
Shares:22.4 million (approximate)
Price:$0.25
Warrants:No
Agent:Chardan Capital Markets, LLC
Pricing date:July 2
Settlement date:July 6
Stock symbol:OTCBB: MYOS
Stock price:$0.47 at close June 30
Market capitalization:$31.9 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.